Double-blind, randomized trial comparing efficacy and safety of continuing olanzapine versus switching to quetiapine in overweight or obese patients with schizophrenia or schizoaffective disorder

We examined the potential risks and benefits of switching from olanzapine to quetiapine in mentally stable, obese, or overweight patients with schizophrenia or schizoaffective disorder. Patients receiving olanzapine were randomized to continuing olanzapine treatment (N =68; 7.5–20 mg/day) or switchi...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Deberdt, Walter, Lipkovich, Ilya, Heinloth, Alexandra N, Liu, Lin, Kollack-Walker, Sara, Edwards, Sara E, Hoffmann, Vicki Poole, Hardy, Thomas A
Materialtyp: Artigo
Språk:Inglês
Publicerad: Dove Medical Press 2008
Ämnen:
Original Research
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC2621385/
https://ncbi.nlm.nih.gov/pubmed/19209252
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk